REQUEST A DEMO
Total
USD $0.00
Search more companies

Inven Pharmaceuticals Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Inven Pharmaceuticals Private Limited Profile Updated: May 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Inven Pharmaceuticals Private Limited is an unlisted company, incorporated on 24/12/1984. It has its registered office in the State of Madhya Pradesh, India. Company's corporate identification number (CIN) is U24232MP1984PTC002701 and registration number is 002701. The company is a manufacturing company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Legal Address
27/1, Patel Nagar Main Road,
Indore; Madhya Pradesh; Postal Code: 452001

Contact Details: Purchase the Inven Pharmaceuticals Private Limited report to view the information.

Basic Information
Outstanding Shares:
Purchase the Inven Pharmaceuticals Private Limited report to view the information.
Registered Capital:
Purchase the Inven Pharmaceuticals Private Limited report to view the information.
Incorporation Date:
December 24, 1984
Key Executives
Purchase this report to view the information.
Whole Time Director
Purchase this report to view the information.
Whole Time Director
Purchase this report to view the information.
Managing Director
Company Performance
Financial values in the chart are available after Inven Pharmaceuticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
13.58%
Total operating revenue
13.56%
Operating profit (EBIT)
468.27%
EBITDA
2.67%
Net Profit (Loss) for the Period
181.46%
Total assets
-2.05%
Total equity
1.21%
Operating Profit Margin (ROS)
0.15%
Net Profit Margin
0.09%
Return on Equity (ROE)
0.76%
Debt to Equity Ratio
-8.77%
Quick Ratio
0.28%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?